Pacific Biosciences of California, Inc.
PACB
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparatioā¦ read more
Healthcare
Medical Devices
15 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$1.76
Price-1.12%
-$0.02
1Y
Price
Market Cap
$528.652m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-89.5%
EBITDA Margin-105.4%
Net Profit Margin-62.7%
Free Cash Flow MarginRevenue
$156.110m
+1.4%
1y CAGR+11.5%
3y CAGR+8.2%
5y CAGREarnings
-$526.359m
-69.9%
1y CAGR-22.8%
3y CAGR-35.5%
5y CAGREPS
-$1.79
-67.3%
1y CAGR-14.0%
3y CAGR-24.9%
5y CAGRBook Value
$61.489m
$825.470m
Assets$763.981m
Liabilities$699.221m
DebtDebt to Assets
84.7%
-6.2x
Debt to EBITDAFree Cash Flow
-$152.315m
+28.2%
1y CAGR+17.8%
3y CAGR-21.5%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company